PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 51 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

19 February 2025

  1. (diff | hist) 11:19 Insulin secretion 5,442 +887 DPP4_Dagmar (talk | contribs) add the reference range with the assay it was established on [rollback]
  2. (diff | hist) 11:07 Talk:Area percent purity 537 +181 IsocraticIla (talk | contribs) /* Detection wavelength: 214 or 220? */ new section
  3. (diff | hist) 09:14 Talk:GL Biochem (Shanghai) 959 +260 ScopeSeverin (talk | contribs) /* Upstream versus retail: is this the same kind of article? */ reply
  4. (diff | hist) 08:53 WuXi TIDES 9,688 ±0 FiveOhThreeB (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  5. (diff | hist) m 03:33 Amylin receptor agonist 3,622 +90 CommaCarys (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]

18 February 2025

  1. (diff | hist) 23:44 Medutest 3,795 ±0 ChainCustodyChad (talk | contribs) fix a dangling clause [rollback]
  2. (diff | hist) m 21:25 International nonproprietary name 3,145 +356 Chromatokid (talk | contribs) expand §Relationship to trade and chemical names [rollback]
  3. (diff | hist) m 18:21 Active pharmaceutical ingredient 2,832 ±0 PharmDrafts (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) m 16:11 Albumin binding half-life extension 4,872 +361 ProglucagonPia (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]
  5. (diff | hist) 14:33 Talk:GL Biochem (Shanghai) 748 +234 ParentCatPansy (talk | contribs) /* Upstream versus retail: is this the same kind of article? */ reply
  6. (diff | hist) 10:07 Talk:GL Biochem (Shanghai) 537 +264 CDMO_Caradoc (talk | contribs) /* Upstream versus retail: is this the same kind of article? */ new section
  7. (diff | hist) 09:33 Talk:Lyophilisation 1,455 +193 Ref_Desk_Ron (talk | contribs) /* Requested move: → Lyophilization */ reply

17 February 2025

  1. (diff | hist) 23:44 Number needed to treat 3,631 +390 FlowTrialFraser (talk | contribs) cite the trial publication rather than the sponsor press release [rollback]
  2. (diff | hist) 20:48 Global access disparity 2,619 +48 ClinicCorrespondent (talk | contribs) add the currency and the date to every price figure [rollback]
  3. (diff | hist) 15:28 ChinaPeptides 6,869 +335 SarcopeniaSefa (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  4. (diff | hist) m 10:41 GLP-1 receptor agonist 9,254 ±0 ReceptorRhoda (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  5. (diff | hist) 09:53 Hypoglycaemia 3,743 +266 LeanMassLars (talk | contribs) state that no head-to-head comparison of tolerability exists for these two [rollback]
  6. (diff | hist) 09:22 Baseline laboratory panel 2,965 +592 DEXA_Dilys (talk | contribs) alphabetise the see-also list [rollback]
  7. (diff | hist) m 06:48 Adverse effects of GLP-1 receptor agonists 4,695 +213 LeanMassLars (talk | contribs) fix hyphenation per PP:MOS [rollback]
  8. (diff | hist) 03:59 Limit of detection 3,971 ±0 BatchNumberBede (talk | contribs) add the plate-count expression and define its terms [rollback]

16 February 2025

  1. (diff | hist) m 23:45 LEADER trial 3,537 +260 SurmountSurma (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) 22:38 Sangon Biotech 5,302 +301 ChainCustodyChad (talk | contribs) copyedit [rollback]
  3. (diff | hist) m 14:30 Methionine oxidation 3,476 +796 DiluentDiya (talk | contribs) expand §Interpretation on a certificate [rollback]
  4. (diff | hist) 13:33 Personal importation policy 3,006 +774 StateBoardStace (talk | contribs) add the patent-expiry statement, attributed and dated [rollback]
  5. (diff | hist) 13:20 Placebo-adjusted effect 3,671 +784 ITT_Imelda (talk | contribs) fix a broken wikilink [rollback]
  6. (diff | hist) m 11:26 SURMOUNT trial programme 3,559 +289 GlossaryGleb (talk | contribs) add the discontinuation rate for adverse events in both arms [rollback]
  7. (diff | hist) 09:47 Preparative HPLC purification 3,866 ±0 UnitsUrsula (talk | contribs) add the collapse-temperature point, sourced [rollback]
  8. (diff | hist) m 09:28 Customs seizure 2,986 +591 PharmDrafts (talk | contribs) ce, tighten prose [rollback]
  9. (diff | hist) 09:25 Glucagon-like peptide-1 10,192 +175 DPP4_Dagmar (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  10. (diff | hist) 07:15 Qingdao Sigma Chemical 8,841 +1,357 BlankVialBo (talk | contribs) add the reception tally with its period and count stated [rollback]
  11. (diff | hist) 01:52 Multi-dose vial 4,366 +1,505 DrTitration (talk | contribs) expand §Reconstituted peptides and multiple withdrawal [rollback]
  12. (diff | hist) m b 01:20 Triple agonist 3,242 +95 CiteBot (talk | contribs) bot: normalise citation format [rollback]

15 February 2025

  1. (diff | hist) 23:54 Electrospray ionisation 3,226 ±0 AAA_Analyst (talk | contribs) typo [rollback]
  2. (diff | hist) 18:03 GLP-1 receptor 6,105 +583 SatietySunniva (talk | contribs) add a figure for the secretion time course and caption it [rollback]
  3. (diff | hist) m b 16:04 Peptide stability table 3,601 +1,517 CiteBot (talk | contribs) bot: normalise unit spacing [rollback]
  4. (diff | hist) m 14:46 Custom peptide synthesis 3,399 +150 CouplingCillian (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  5. (diff | hist) 12:59 STEP trial programme 4,357 ±0 AnalyticalAnnie (talk | contribs) the article attributed a finding to the wrong trial in the programme [rollback]
  6. (diff | hist) 12:33 Dual incretin agonist 4,734 +147 BacWaterBarnaby (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  7. (diff | hist) m 00:04 Amino acid analysis 2,621 ±0 Areapercent_Ayo (talk | contribs) fix a broken wikilink [rollback]

14 February 2025

  1. (diff | hist) 23:57 Batch number 3,708 ±0 VerifyVesna (talk | contribs) add the turnaround time the service publishes [rollback]
  2. (diff | hist) 13:25 SELECT trial 4,206 ±0 NNT_Nerys (talk | contribs) add the year of publication to each trial in the list [rollback]
  3. (diff | hist) 12:57 Semaglutide 8,079 +981 FreightFenna (talk | contribs) fix the anchor on an internal link [rollback]
  4. (diff | hist) m b 10:44 Bachem Holding (Suzhou) 8,101 +860 CategoryBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) 10:26 Talk:Chinese Peptide Company 1,033 +60 Hedgerow_Hal (talk | contribs) /* Requested move: → Chinese Peptide Company Co., Ltd. */ reply
  6. (diff | hist) 07:21 Reconstitution calculator 5,276 +820 SourceHunterSile (talk | contribs) add a second default preset at a common vial strength [rollback]

13 February 2025

  1. (diff | hist) 20:08 Dose escalation schedule 3,510 ±0 PreregPriya (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  2. (diff | hist) 19:12 VendorInvestigate 4,188 +603 SurrogateSunday (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  3. (diff | hist) m 17:34 Vial 17,729 +597 Chromatokid (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  4. (diff | hist) 10:14 Talk:Lyophilisation 1,244 +262 LyophilLena (talk | contribs) /* Requested move: → Lyophilization */ reply
  5. (diff | hist) 06:57 Peptide harm reduction 2,785 ±0 ReaderRosalie (talk | contribs) expand §What the uncertainties are [rollback]
  6. (diff | hist) m 06:35 Reconstitution of lyophilised peptides 4,389 +216 TesamorelinTeg (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  7. (diff | hist) m 05:17 Orforglipron 3,337 ±0 LiraLotte (talk | contribs) typo [rollback]
  8. (diff | hist) 02:54 Regulatory status by jurisdiction 2,721 ±0 Areapercent_Ayo (talk | contribs) split overlong sentence [rollback]
  9. (diff | hist) m b 00:45 FLOW trial 3,169 +72 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]

12 February 2025

  1. (diff | hist) m 22:43 Liraglutide 4,295 ±0 LotTraceLuka (talk | contribs) add the peptide length to the infobox [rollback]
  2. (diff | hist) m 15:29 Test report forgery 3,991 +117 BUD_Bertram (talk | contribs) add short description [rollback]
  3. (diff | hist) 13:47 Talk:Lyophilisation 1,033 +173 MoveRequestMio (talk | contribs) /* Requested move: → Lyophilization */ reply
  4. (diff | hist) m 11:23 Prior authorisation 2,250 ±0 SigFigSindri (talk | contribs) split §Pricing from §Coverage [rollback]
  5. (diff | hist) 10:34 Patent expiry and biosimilars 2,578 ±0 BaselineBex (talk | contribs) name the regulator rather than writing "the authorities" [rollback]
  6. (diff | hist) 09:03 Talk:Hubei Jianxiang Bioscience 959 +169 StyleSheetSybil (talk | contribs) /* Should the peptide-content explanation live here? */ reply
  7. (diff | hist) 08:05 Talk:Lyophilisation 822 +226 HyphenHarriet (talk | contribs) /* Requested move: → Lyophilization */ reply
  8. (diff | hist) m 08:03 Blind sampling 5,650 +676 Chromatokid (talk | contribs) add the retest interval and what triggers one [rollback]
  9. (diff | hist) m b 07:29 HOMA-IR 3,311 +103 ArchiveBot (talk | contribs) bot: add stub category [rollback]
  10. (diff | hist) 05:52 Contract development and manufacturing organisation 2,875 ±0 CDMO_Caradoc (talk | contribs) add the collapse-temperature point, sourced [rollback]
  11. (diff | hist) 00:30 MOTS-c 2,663 ±0 RotationRosalind (talk | contribs) rm the aggregate purity claim — no source, and no such survey exists [rollback]

11 February 2025

  1. (diff | hist) 18:02 Multi-dose vial 2,861 +784 DrTitration (talk | contribs) correct the label on the second column — that is volume, not mass [rollback]
  2. (diff | hist) 15:34 Subcutaneous injection 4,039 ±0 EscalationEira (talk | contribs) rm the brand-specific instruction; it is not general [rollback]
  3. (diff | hist) 14:19 Talk:Hubei Jianxiang Bioscience 748 +377 AnalyticalAnnie (talk | contribs) /* Should the peptide-content explanation live here? */ reply
  4. (diff | hist) 12:51 Lot traceability 4,002 ±0 TierTwoTansy (talk | contribs) add category for certificates of analysis [rollback]
  5. (diff | hist) 11:22 Talk:Lyophilisation 611 +402 StyleSheetSybil (talk | contribs) /* Requested move: → Lyophilization */ reply
  6. (diff | hist) 10:44 Talk:Hubei Jianxiang Bioscience 537 +234 HyphenHarriet (talk | contribs) /* Should the peptide-content explanation live here? */ new section
  7. (diff | hist) 09:40 Talk:Lyophilisation 400 +355 MoveRequestMio (talk | contribs) /* Requested move: → Lyophilization */ new section
  8. (diff | hist) 07:04 Cost per milligram 2,123 +206 TimelineTiernan (talk | contribs) add the manufacturer assistance programme with its eligibility criterion [rollback]
  9. (diff | hist) 06:18 Counterfeit peptide 2,733 ±0 StateBoardStace (talk | contribs) rm a duplicated category [rollback]
  10. (diff | hist) 03:03 Analytical method validation 4,021 ±0 SigFigSindri (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  11. (diff | hist) m 02:55 Cold chain 18,483 +506 BUD_Bertram (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]

10 February 2025

  1. (diff | hist) m 22:43 Dulaglutide 3,990 ±0 SVG_Solomon (talk | contribs) add see also to the amylin analogue [rollback]
  2. (diff | hist) 21:52 Lixisenatide 3,035 +99 CuriousCallum (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  3. (diff | hist) m 20:18 High-performance liquid chromatography 5,364 ±0 IncretinIvo (talk | contribs) add the plate-count expression and define its terms [rollback]
  4. (diff | hist) m 14:28 Retatrutide 5,700 ±0 SurvodutideSaff (talk | contribs) add the structural figure and caption it properly [rollback]
  5. (diff | hist) m 13:25 Injection site rotation 3,897 +342 Hedgerow_Hal (talk | contribs) state the syringe graduation the unit figure assumes [rollback]
  6. (diff | hist) m 12:38 Shanghai Sigma-Audley New Material Technology 6,669 +467 ParentCatPansy (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  7. (diff | hist) m b 10:38 Tianjin Finder Chemical 6,168 +351 StubSorterBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]
  8. (diff | hist) 09:52 Talk:Chinese Peptide Company 822 +146 DisambigDenzil (talk | contribs) /* Requested move: → Chinese Peptide Company Co., Ltd. */ reply
  9. (diff | hist) m 02:40 Cold-chain freight 3,111 +26 StopperingSteff (talk | contribs) clarify that "cold chain" without a logger is a claim, not a record [rollback]
  10. (diff | hist) m 00:47 Trial data comparison 2,396 +176 Ref_Desk_Ron (talk | contribs) add the caveat that concentration and dose are not the same quantity [rollback]

9 February 2025

  1. (diff | hist) 20:32 SURPASS trial programme 3,958 ±0 EndpointEnid (talk | contribs) add the trial registration identifier [rollback]
  2. (diff | hist) 14:38 Talk:Chinese Peptide Company 611 +301 INN_Ingrid (talk | contribs) /* Requested move: → Chinese Peptide Company Co., Ltd. */ reply
  3. (diff | hist) 13:47 Lyophilisation 17,642 +766 EmptyingElke (talk | contribs) convert the storage conditions to a table [rollback]
  4. (diff | hist) m b 13:00 USP General Chapter 85 3,451 +35 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  5. (diff | hist) 11:34 Melanotan II 3,358 +655 MolarMassMaeve (talk | contribs) move a stray full stop inside the reference [rollback]
  6. (diff | hist) 11:14 Talk:Chinese Peptide Company 400 +310 MoveRequestMio (talk | contribs) /* Requested move: → Chinese Peptide Company Co., Ltd. */ new section
  7. (diff | hist) 08:08 Insulin syringe unit conversion 3,540 +335 NPOV_Nadia (talk | contribs) add category for interactive reference tools [rollback]
  8. (diff | hist) 05:28 Vial filling and stoppering 3,355 ±0 DiluentDiya (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  9. (diff | hist) m 01:50 Global access disparity 2,571 +376 OffLabelOdile (talk | contribs) attribute the affordability estimate to the analysis it comes from [rollback]

8 February 2025

  1. (diff | hist) 20:48 Repackaging 3,937 +340 FreightFenna (talk | contribs) sentence case in headings per PP:MOS [rollback]
  2. (diff | hist) 17:31 Research use only 6,689 +27 PurityClaimPia (talk | contribs) clarify that personal importation and commercial importation are different questions [rollback]
  3. (diff | hist) m 16:48 Timeline of incretin therapeutics 3,151 ±0 CagriCass (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  4. (diff | hist) 13:40 Crude peptide 3,651 +333 IncretinIvo (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]
  5. (diff | hist) 13:39 PeptideMeter 3,734 ±0 EscalationEira (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]